Published date: 23 December 2020

This notice was replaced on 12 March 2021

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Future opportunity (published 12 March 2021)

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Contract summary

Industry

  • Urology, exploration devices - 33125000

Location of contract

Any region

Value of contract

£24,000,000

Procurement reference

tender_260809/912538

Published date

23 December 2020

Approach to market date

1 June 2022

Contract start date

7 September 2022

Contract end date

6 September 2026

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

This agreement is for transperineal access devices. Predominantly, the device allows the user to perform
transperineal prostate biopsies under local anaesthetic. Precise quantities are unknown. It is anticipated
that initial expenditure will be in the region of £4,000,000 to £6,000,000 in the first year of this Framework
Agreement, however this is approximate only and the values may vary depending on the requirements of those
bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement
term is £24,000,000. This has the potential to increase depending on patient pathway decisions made.

About the buyer

Address

NHS Supply Chain, Unit 5 Telford Court, Chester Gates, Dunkirk Trading Estate
Chester
CH1 6LT
England

Email

chelsea.allen2@supplychain.nhs.uk